Future therapy of hepatitis C
Open Access
- 1 November 2002
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 36 (S1), S245-S252
- https://doi.org/10.1002/hep.1840360731
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Developments in the treatment of chronic hepatitis CExpert Opinion on Investigational Drugs, 2002
- Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAsHepatology, 2002
- New therapeutic strategies for hepatitis CHepatology, 2002
- Activation of hepatic stellate cells - a key issue in liver fibrosisFrontiers in Bioscience-Landmark, 2002
- Amantadine for chronic hepatitis C: a magic bullet or yet another dead duck?Journal of Hepatology, 2001
- Beneficial effects of silymarin on estrogen-induced cholestasis in the rat: A study in vivo and in isolated hepatocyte coupletsHepatology, 2001
- Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigensHepatology, 2001
- Occurrence of identical hypervariable region 1 sequences of hepatitis C virus in transfusion recipients and their respective blood donors: Divergence over timeHepatology, 2001
- Pharmacokinetics and Tissue Distribution of a Ribozyme Directed Against Hepatitis C Virus RNA Following Subcutaneous or Intravenous Administration in MiceHepatology, 2000
- A Preliminary Study of Long-Term Treatment with Interferon Gamma-1b and Low-Dose Prednisolone in Patients with Idiopathic Pulmonary FibrosisNew England Journal of Medicine, 1999